Many addiction counselors were trained in the rich tradition of 12-Step recovery programs, yet staying abreast of emerging evidence-based practices may require a counselor to look beyond his or her initial training. One area of new information that may benefit the field of addiction treatment involves the use of medications as an adjunct to the counseling and behavioral therapies that have been widely embraced by psychosocial treatment programs. This on-line course is designed to enhance the counselor’s depth of understanding of addiction as a brain disease, and to encourage counselors to consider the role medications might play in improving treatment outcomes for some individuals with substance abuse problems.
LEARNING OBJECTIVES
At the conclusion of this program participants will be able to
| • | Describe the disease concept of addiction as it relates to neurobiology. |
| • | Identify pharmacotherapies currently available for use in addiction treatment. |
| • | Discuss barriers to using pharmacotherapies in practice settings, as well as possible strategies to overcome these barriers. |
TARGET AUDIENCE
| • | Addiction counselors |
| • | Human service providers with an interest in addiction treatment |
PROGRAM AGENDA
Introduction
Lynn McKnight, LPC/S, MAC, CCS
Addiction as a Brain Disease
Susan Sonne, PharmD, BCPP
Currently Approved Medications for Addiction Treatment
Susan Sonne, PharmD, BCPP
Questions and Answers
Lynn McKnight, LPC/S, MAC, CCS; Louise Haynes, MSW; Susan Sonne, PharmD, BCPP FACULTY
Susan Sonne, PharmD, BCPP
Associate Professor of Psychiatry
Medical University of South Carolina
Institute of Psychiatry
Charleston, South Carolina
Louise Haynes, MSW
Director of Research
Lexington/Richland Alcohol and Drug Abuse Council
Columbia, South Carolina
Lynn McKnight, LPC/S, MAC, CCS
Treatment Director and Clinical Supervisor
Charleston County Department of Alcohol and Other Drug Abuse Services
Charleston, South Carolina
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the National Association of Alcohol and Drug Abuse Counselors (NAADAC) continuing education standards.
CREDIT DESIGNATION
The Medical University of South Carolina designates this educational activity for a maximum of 2.0 continuing education hours. The Medical University of South Carolina awards 0.1 CEU per contact hour to each non-physician participant who successfully completes this educational activity. The CEU (Continuing Education Unit) is a nationally recognized unit of measure for continuing education and training activities that meet specific educational planning requirements. The Medical University of South Carolina maintains a permanent record of participants who have been awarded CEUs.
NAADAC
This course has been approved by the National Association of Alcoholism and Drug Abuse Counselors for 2 contact hours. Provider #649. FACULTY BIOGRAPHIES
Lynn McKnight, LPC/S, MAC, CCS
Lynn McKnight is the Treatment Director and Clinical Supervisor of the Charleston County Department of Alcohol and Other Drug Abuse Services, and has been in the AOD and mental health field for over 25 years. She is a national trainer in Motivational Interviewing and Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency (MIA-STEP) protocol, and president of the South Carolina Art Therapy Association. She has recently accepted the position of Clinical Director at Crossroads Center, Antigua.
Susan Sonne, PharmD, BCPP
Susan Sonne has over 15 years of experience in the use of medications to treat addictions and co-occurring psychiatric disorders. She is currently employed by the Medical University of South Carolina as an Associate Professor of Psychiatry and Pharmacy, and also serves as the Co-Principal Investigator of the Southern Consortium Node of the Clinical Trials Network.
Louise Haynes, MSW
Louise Haynes has over 20 years of experience in the substance abuse field, and is the current Community Treatment Program Representative for the Clinical Trials Network for the Southern Consortium Node, and the Director of Research for LRADAC. Ms. Haynes is an Adjunct Assistant Professor in the Department of Psychiatry at the Medical University of South Carolina.
DISCLOSURES
Louise Haynes, MSW, has no relevant financial relationship with a commercial interest to disclose.
Lynn McKnight, LPC/S, MAC, CCS, has no relevant financial relationship with a commercial interest to disclose.
Susan Sonne, PharmD, BCPP, has disclosed the following relevant financial relationships: she is on the speakers’ bureau for Forest Laboratories, and has received grant support from Forest Laboratories.
